Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2022
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, et al.
Nature Communications
|
February 10, 2023
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, et al.
Cancer Cell
|
April 2, 2021
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
Alice Bertocchi, Sara Carloni, Paola Simona Ravenda, et al.
Annals of Surgery
|
April 12, 2019
Definition of the Rectum: An International, Expert-based Delphi Consensus
Nigel DʼSouza, Michael P M de Neree Tot Babberich, Andre d'Hoore, et al.
Cancer Research
|
December 15, 2010
Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase
Arijit Chakravarty, Vaishali Shinde, Josep Tabernero, et al.
Cancer Discovery
|
January 30, 2013
First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement
Josep Tabernero, Geoffrey I Shapiro, Patricia M LoRusso, et al.
Cancer Discovery
|
September 22, 2025
The molecular and functional landscape of resistance to FOLFIRI chemotherapy in metastatic colorectal cancer
Marco Avolio, Simonetta M Leto, Francesco Sassi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2017
Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity
Didier Meulendijks, Wolfgang Jacob, Emile E Voest, et al.
Nature Medicine
|
December 5, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Jayesh Desai, Guzman Alonso, Se Hyun Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2013
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum
Cornelis J H van de Velde, Petra G Boelens, Josep M Borras, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 14, 2022
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Tae Won Kim, Howard A Burris, Maria J de Miguel Luken, et al.
Nature Communications
|
February 10, 2023
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, et al.
Cancer Cell
|
April 2, 2021
Gut vascular barrier impairment leads to intestinal bacteria dissemination and colorectal cancer metastasis to liver
Alice Bertocchi, Sara Carloni, Paola Simona Ravenda, et al.
Annals of Surgery
|
April 12, 2019
Definition of the Rectum: An International, Expert-based Delphi Consensus
Nigel DʼSouza, Michael P M de Neree Tot Babberich, Andre d'Hoore, et al.
Cancer Research
|
December 15, 2010
Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase
Arijit Chakravarty, Vaishali Shinde, Josep Tabernero, et al.
Cancer Discovery
|
January 30, 2013
First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement
Josep Tabernero, Geoffrey I Shapiro, Patricia M LoRusso, et al.
Cancer Discovery
|
September 22, 2025
The molecular and functional landscape of resistance to FOLFIRI chemotherapy in metastatic colorectal cancer
Marco Avolio, Simonetta M Leto, Francesco Sassi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2017
Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity
Didier Meulendijks, Wolfgang Jacob, Emile E Voest, et al.
Nature Medicine
|
December 5, 2023
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Jayesh Desai, Guzman Alonso, Se Hyun Kim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2013
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum
Cornelis J H van de Velde, Petra G Boelens, Josep M Borras, et al.
Page
of 8